Major indices finish lower amid GE earnings disappointment >>> READ MORE

5 Lean, Mean Profit Machines

These companies squeeze plenty of profits from their workers

    View All  

Gilead Sciences

Gilead Sciences NASDAQ:GILDEmployees: 3,441
Profit Per Employee: $610,931

Biopharmacuetical company Gilead Sciences (NASDAQ:GILD) is focused in treatments for HIV/AIDS, liver diseases such as hepatitis B and C, and cardiovascular/metabolic and respiratory conditions.

With revenues of more than $2 billion, the 25-year old company is well-positioned in the biopharma world.

Premium pricings on its treatments help push Gilead forward on profit per employee, and its margins keep expanding.

Marc Bastow is an Assistant Editor at As of this writing, he did not hold a position in any of the aforementioned securities.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC